Kimberly Shepard

Oct 18, 2024 | outsourcedpharma.com | Louis Garguilo |Yadnyesh Patel |Kimberly Shepard

Components of the WuXi global organization are for sale. It’s a forced divestiture. WuXi AppTec is marketing some of its U.S. and European operations. The ill-advised BIOSECURE Act targeting several China-based biopharma companies is having its intended effects, even before the legislation is fully passed by the U.S. government. Where do you stand?

Jul 30, 2024 | drugdiscoveryonline.com | Jie Huang |Kimberly Shepard |Amanda M. Pluntze

Developing and ultimately obtaining approval of cell therapies for solid tumors requires an organized and scientifically rigorous approach. This article is a helpful road map of considerations. Simultaneous Spray Drying For Combination Dry Powder Inhaler FormulationsThree combination case studies are demonstrated, in which bevacizumab is paired with erlotinib, cisplatin, or paclitaxel in a dry powder inhaler formulation.

Apr 26, 2024 | outsourcedpharma.com | Kate Coleman |Mark Ignaczak |Kimberly Shepard |Louis Garguilo

Outsourced Pharma Capacity Update covers the entire pharmaceutical product formulation, manufacturing, and packaging spectrum, emphasizing process development and GMP compliance. Explore innovative solutions from CDMOs with capacity during our new PARTNER WEEK for solid orals, liquid orals, semi-solid, and specialty dosage forms. Register today for the Small Molecule Finished Dosage Form session happening May 22nd.

Jun 5, 2023 | outsourcedpharma.com | Srihari Rangarajan |Nathan Dormer |Kimberly Shepard |Amanda M. Pluntze |Louis Garguilo

By Outsourced Pharma Outsourced Pharma chief editor, Louis Garguilo, briefly interviews Dirk T. Lange, head of life science services, MilliporeSigma, at the 2023 CDMO Leadership Awards ceremony in Manhattan. Lange discusses MilliporeSigma’s awards, the "team sport" mentality, efforts behind the organization, and bringing clients' ideas to fruition.   By Mark Roache, Quality Executive Partners, Inc.